What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Disease
His primary scientific interests are in Internal medicine, COPD, Surgery, Respiratory disease and Physical therapy.
His Internal medicine study frequently draws connections between related disciplines such as Cardiology.
His research in COPD intersects with topics in Vital capacity, Cohort study, Pulmonary function testing, Severity of illness and Pediatrics.
The concepts of his Respiratory disease study are interwoven with issues in Gastroenterology, Lung volumes, Cause of death, Asthma and Health education.
His work deals with themes such as Corticosteroid and Etiology, which intersect with Asthma.
His work carried out in the field of Physical therapy brings together such families of science as Obstructive lung disease and MEDLINE.
His most cited work include:
- A 15-year follow-up study of ventilatory function in adults with asthma. (1054 citations)
- Prognostic value of nutritional status in chronic obstructive pulmonary disease (823 citations)
- Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study (775 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, COPD, Physical therapy, Pulmonary disease and Cardiology.
His Internal medicine research focuses on Surgery and how it relates to Respiratory disease.
He has included themes like Exacerbation, Prospective cohort study, Spirometry and Intensive care medicine in his COPD study.
His research in Spirometry intersects with topics in Vital capacity and FEV1/FVC ratio.
His study in Physical therapy is interdisciplinary in nature, drawing from both Obstructive lung disease, Severity of illness and Epidemiology.
His biological study spans a wide range of topics, including Young adult and Pediatrics.
He most often published in these fields:
- Internal medicine (65.93%)
- COPD (64.04%)
- Physical therapy (27.29%)
What were the highlights of his more recent work (between 2017-2021)?
- COPD (64.04%)
- Internal medicine (65.93%)
- Fluticasone propionate (8.52%)
In recent papers he was focusing on the following fields of study:
Peter Lange spends much of his time researching COPD, Internal medicine, Fluticasone propionate, Exacerbation and Vilanterol.
His COPD research incorporates themes from Pulmonary disease, Hazard ratio, Cohort study and Population study.
His Population study research includes elements of FEV1/FVC ratio, Chronic bronchitis, Chronic cough, Prospective cohort study and Spirometry.
His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Cardiology.
His Fluticasone propionate research incorporates elements of Fluticasone and Medication use.
Peter Lange combines subjects such as Randomized controlled trial, Quality of life, Pulmonary rehabilitation, Proportional hazards model and Lung function with his study of Exacerbation.
Between 2017 and 2021, his most popular works were:
- Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD (398 citations)
- Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial (62 citations)
- Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial (62 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Disease
His scientific interests lie mostly in Internal medicine, COPD, Exacerbation, Population study and Pulmonary disease.
In his work, Inhalation is strongly intertwined with Gastroenterology, which is a subfield of Internal medicine.
His COPD study integrates concerns from other disciplines, such as Vilanterol, Lung function, Fluticasone propionate, Cardiology and Fluticasone.
His Exacerbation research is multidisciplinary, relying on both Schizophrenia, Blood eosinophil, Randomized controlled trial and Quality of life, Pulmonary rehabilitation.
The various areas that Peter Lange examines in his Population study study include Prospective cohort study and FEV1/FVC ratio.
His studies in Pulmonary disease integrate themes in fields like Cardiorespiratory fitness, Risk of death and Long term risk.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
